AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposia presentation..
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science can do.
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally.
We have three priorities designed to deliver our growth through innovation strategy.
Accelerate Innovative Science
Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity
Deliver Growth and Therapy Area Leadership
Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition
Be a Great Place to Work
Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon programmeVisit their website >
Learn more about the event